Pre-Market Review on Active Stocks -- Research on Louisiana-Pacific, ArcelorMittal, NPS Pharma, and Investors Bancorp - 100.7 Jack FM San Diego Radio & DSC- sandiegojack

Pre-Market Review on Active Stocks -- Research on Louisiana-Pacific, ArcelorMittal, NPS Pharma, and Investors Bancorp

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Investor-Edge

Editor Note: For more information about this release, please scroll to bottom.

LONDON, May 9, 2014 /PRNewswire/ --

The markets on Thursday, May 08, 2014 ended on a mixed note as the Dow Jones Industrial Average finished at 16,550.97, up 0.20% and the NASDAQ Composite closed at 4,051.50, down 0.40%. The S&P 500 edged 0.14% lower, to finish the day at 1,875.63. During the session, five out of ten sectors finished on a positive note. The session saw a positive impact from Telecommunication Services, Consumer Discretionary and Financials sectors along with a drag from Energy, Utilities and Health Care sectors. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Louisiana-Pacific Corporation (NYSE: LPX), ArcelorMittal (NYSE: MT), NPS Pharmaceuticals Inc. (NASDAQ: NPSP) and Investors Bancorp Inc. (NASDAQ: ISBC). Free technical research on LPX, MT, NPSP and ISBC can be downloaded upon signing up at:

http://www.investor-edge.com/2337-register

On Thursday, Louisiana-Pacific Corp.'s stock declined 3.02%, closing the day at $15.43. The stock recorded a trading volume of 12.78 million shares, much above to its three months average volume of 2.73 million shares. The stock oscillated between $14.87 and $16.94 during the trading session. Louisiana-Pacific Corp.'s shares have declined 6.37% in the previous three trading sessions, 6.26% in the last one month and 16.64% On YTD basis. The S&P 500 Materials Sector Index gained 6.64% in the previous three months, while the S&P 500 advanced 4.37% during the same period. Louisiana-Pacific Corp.'s stock is trading below its 50-day and 200-day moving averages of $16.72 and $16.94, respectively. Moreover, shares of the company traded at a PE ratio of 22.44 and have a Relative Strength Index (RSI) of 45.61. Sign up today to read free research on LPX at:

http://www.investor-edge.com/2337-LPX-09May2014.pdf

Shares in ArcelorMittal traded between $16.28 and $16.60 before ending the day 1.30% higher at $16.35. The company's stock reported a trading volume of 7.25 million shares on Thursday, which was much above to its three months average volume of 5.10 million shares. Although ArcelorMittal shares have advanced 1.81% in the previous three trading sessions, it has declined 0.97% in the last one month and 8.35% on YTD basis.The S&P 500 Materials Sector Index gained 1.84% in the last one month, while the S&P 500 advanced 1.28% during the same period. The stock is trading above its 50-day and 200-day moving averages. ArcelorMittal's 50-day moving average of $15.87 is greater than its 200-day moving average of $15.58. Additionally, the company's stock has an RSI of 49.74. Sign up today to read free research on MT at:

http://www.investor-edge.com/2337-MT-09May2014.pdf

On Thursday, shares in NPS Pharmaceuticals Inc. recorded a trading volume of 9.00 million shares, which was above its three months average volume of 2.04 million shares. The stock finished the day at $24.17, which was 10.61% lower to its previous day's closing, and registered an intraday range of $22.68 and $26.95. NPS Pharmaceuticals Inc.'s shares have plummeted 15.61% in the previous three trading sessions and 7.29% in the last one month. Additionally, from the beginning of the 2014, stock has declined 20.39%. The company's stock is trading below its 50-day and 200-day moving averages of $29.23 and $28.80, respectively. Furthermore, shares of the company have an RSI of 49.10.On the same day, NPS Pharmaceuticals Inc. announced its Q1 FY 2014 financial results (period ended March 31, 2014). For Q1 FY 2014, the company reported net loss attributable to NPS Pharmaceuticals Inc. of $6.6 million, or $0.06 per diluted share. Sign up today to read free research on NPSP at:

http://www.investor-edge.com/2337-NPSP-09May2014.pdf

Investors Bancorp Inc.'s stock closed Thursday's session 0.97% lower at $10.42. A total of 44.54 million shares were traded, which was above its three months average volume of 1.76 million shares. The stock moved between $10.30 and $10.49 during the session. Over the last three months and since start of this year, Investors Bancorp Inc.'s shares have gained 5.15% and 3.87%, respectively. However, the company's stock has lost 1.04% in the last one month. Share of the company traded at a PE ratio of 25.07. The S&P 500 Financials Sector Index advanced 3.04% in the last three months, while the NASDAQ Composite Index has fallen by 1.80% during the same period. The company's shares are trading above their 200-day moving average of $9.55, while the 200-day moving average is below Investors Bancorp Inc.'s 50-day moving average of $10.59. Further, Investors Bancorp Inc.'s stock has an RSI of 50.55. Sign up today to read free research on ISBC at:

http://www.investor-edge.com/2337-ISBC-09May2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and Midwest Television, Inc. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.